Tuesday, April 10, 2012



Announces

Announces
Are you searching for Announces information? Here at http://www.liposome.org you can find lots of free Announces articles, advice, how-to and so much more.

Announces

Please browse our growing free database of Announces content below.


Announces

Celsion Announces ThermoDoxR HEAT Study to Be Discussed at 7th Annual ... SYSCON Media Press Release

by Liposomes

Celsion Announces ThermoDox(R) HEAT Study to Be Discussed at 7th Annual ...SYS-CON Media (press release)Localized mild hyperthermia (39.5 - 42 degrees Celsius) created by the RFA releases the entrapped doxorubicin from the liposome. This delivery technology enables high concentrations of doxorubicin to be deposited preferentially in a targeted tumor. ... and more& » Read the [...]

Full Liposome | Lipid Vesicle post →

Pacira Pharmaceuticals Inc. Announces EXPAREL™ Data Presentations at the ... PR Newswire Press Release

by Liposomes

Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations at the ...PR Newswire (press release)Dr. Viscusi's presentation, titled "The Safety of EXPAREL™, A Multivesicular Liposomal Extended-Release Bupivacaine" examines the safety profile of EXPAREL in 823 patients across ten wound infiltration studies and five surgical procedures, ... and more& » Read the full story: Pacira Pharmaceuticals, Inc. Announces [...]

Full Liposome | Lipid Vesicle post →

Celsion Announces Unanimous Recommendation by Independent Data Monitoring ... MarketWatch Press Release

by Liposomes

Celsion Announces Unanimous Recommendation by Independent Data Monitoring ...MarketWatch (press release)Localized mild hyperthermia (39.5 - 42 degrees Celsius) created by the RFA releases the entrapped doxorubicin from the liposome. This delivery technology enables high concentrations of doxorubicin to be deposited preferentially in a targeted tumor. ... and more& » Read the full story: Celsion Announces [...]

Full Liposome | Lipid Vesicle post →

Pacira Pharmaceuticals Inc. Announces Pricing of FollowOn Offering MarketWatch Press Release

by Liposomes

Pacira Pharmaceuticals, Inc. Announces Pricing of Follow-On OfferingMarketWatch (press release)The company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL(TM) (bupivacaine liposome injectable suspension), was approved for administration into the surgical site to produce ... and more& » Read the full story: Pacira Pharmaceuticals, Inc. Announces Pricing [...]

Full Liposome | Lipid Vesicle post →

Pacira Pharmaceuticals Inc. Announces Pricing of FollowOn Offering Sacramento Bee

by Liposomes

Pacira Pharmaceuticals, Inc. Announces Pricing of Follow-On OfferingSacramento BeeThe company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL™ (bupivacaine liposome injectable suspension), was approved for administration into the surgical site to produce ... and more& » Read the full story: Pacira Pharmaceuticals, Inc. Announces Pricing of [...]

Full Liposome | Lipid Vesicle post →

Pacira Pharmaceuticals Inc. Announces EXPAREL™ Data Presentations PR Newswire Press Release

by Liposomes

Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data PresentationsPR Newswire (press release)Dr. Bergese's presentation, titled "EXPAREL™ (Bupivacaine Extended-Release Liposome Injection), An Investigational Analgesic, Provides Postsurgical Pain Relief and Decreased Opioid Use as Demonstrated by Integrated Analysis" evaluated the extent and ... and more& » Read the full story: Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations - PR [...]

Full Liposome | Lipid Vesicle post →

Gilead Sciences Announces First Quarter 2011 Financial Results Insurance News Net Press Release

by Liposomes

Gilead Sciences Announces First Quarter 2011 Financial ResultsInsurance News Net (press release)Sales of other products were $147.1 million for the first quarter of 2011 compared to $150.0 million for the first quarter of 2010 and included AmBisome ® (amphotericin B) liposome for injection for the treatment of severe fungal infections, ... and more& » Read [...]

Full Liposome | Lipid Vesicle post →

Pacira Pharmaceuticals Inc. Announces EXPAREL™ Data to Be Presented at ... PR Newswire Press Release

by Liposomes

Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data to Be Presented at ...PR Newswire (press release)Poster Title: Bupivacaine Extended Release Liposome Injection (DepoFoam® bupivacaine) vs. Bupivacaine HCl: A Meta-analysis of Multimodal Trials of Doses Up to and Including 300 mg Following the meeting, the posters will be available on the scientific ... and more& » Read the [...]

Full Liposome | Lipid Vesicle post →

Oncothyreon Announces Presentations at Upcoming Scientific and Investor ... PRUSA.net Press Release

by Liposomes

Oncothyreon Announces Presentations at Upcoming Scientific and Investor ...PR-USA.net (press release)Dr. Peterson's presentation titled "Liposome Vaccines Designed to Induce Immune Response to Cancer Cells Expressing MUC1" will highlight preclinical data on ONT-10. Oncothyreon is a biotechnology company specializing in the development of innovative ... and more& » Read the full story: Oncothyreon Announces Presentations at [...]

Full Liposome | Lipid Vesicle post →

Celator(R) Pharmaceuticals Announces Positive Data From Phase 2 Study of CPX-351 in Acute Myeloid Leukemia

by Liposomes

Celator(R) Pharmaceuticals Announces Positive Data From Phase 2 Study of CPX-351 in Acute Myeloid Leukemia Celator Pharmaceuticals, Inc. today announced positive results from its Phase 2 study of CPX-351 Liposome Injection versus conventional cytarabine and daunorubicin in patients, 60-75 years of age, with untreated acute myeloid leukemia . The primary endpoint of the study, the [...]

Full Liposome | Lipid Vesicle post →

← Previous Entries